Literature DB >> 24814322

Are investments in disease prevention complements? The case of statins and health behaviors.

Robert Kaestner1, Michael Darden2, Darius Lakdawalla3.   

Abstract

We obtain estimates of associations between statin use and health behaviors. Statin use is associated with a small increase in BMI and moderate (20-33%) increases in the probability of being obese. Statin use was also associated with a significant (e.g., 15% of mean) increase in moderate alcohol use among men. There was no consistent evidence of a decrease in smoking associated with statin use, and exercise worsened somewhat for females. Statin use was associated with increased physical activity among males. Finally, there was evidence that statin use increased the use of blood pressure medication and aspirin for both males and females, although estimates varied considerably in magnitude. These results are consistent with the hypothesis that healthy diet is a strong substitute for statins, but there is only uneven evidence for the hypothesis that investments in disease prevention are complementary.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Complementarity; Health behaviors; Health investment; Prevention; Statins

Mesh:

Substances:

Year:  2014        PMID: 24814322      PMCID: PMC4063305          DOI: 10.1016/j.jhealeco.2014.04.006

Source DB:  PubMed          Journal:  J Health Econ        ISSN: 0167-6296            Impact factor:   3.883


  40 in total

Review 1.  Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials.

Authors:  Paaladinesh Thavendiranathan; Akshay Bagai; M Alan Brookhart; Niteesh K Choudhry
Journal:  Arch Intern Med       Date:  2006-11-27

2.  A low-fat vegan diet improves glycemic control and cardiovascular risk factors in a randomized clinical trial in individuals with type 2 diabetes.

Authors:  Neal D Barnard; Joshua Cohen; David J A Jenkins; Gabrielle Turner-McGrievy; Lise Gloede; Brent Jaster; Kim Seidl; Amber A Green; Stanley Talpers
Journal:  Diabetes Care       Date:  2006-08       Impact factor: 19.112

3.  Intensive lifestyle changes for reversal of coronary heart disease.

Authors:  D Ornish; L W Scherwitz; J H Billings; S E Brown; K L Gould; T A Merritt; S Sparler; W T Armstrong; T A Ports; R L Kirkeeide; C Hogeboom; R J Brand
Journal:  JAMA       Date:  1998-12-16       Impact factor: 56.272

4.  Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data.

Authors:  W Y Craig; G E Palomaki; J E Haddow
Journal:  BMJ       Date:  1989-03-25

5.  Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

Authors:  C Baigent; A Keech; P M Kearney; L Blackwell; G Buck; C Pollicino; A Kirby; T Sourjina; R Peto; R Collins; R Simes
Journal:  Lancet       Date:  2005-09-27       Impact factor: 79.321

6.  Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Authors: 
Journal:  JAMA       Date:  1993-06-16       Impact factor: 56.272

7.  The relative influence of secondary versus primary prevention using the National Cholesterol Education Program Adult Treatment Panel II guidelines.

Authors:  L Goldman; P Coxson; M G Hunink; P A Goldman; A N Tosteson; M Mittleman; L Williams; M C Weinstein
Journal:  J Am Coll Cardiol       Date:  1999-09       Impact factor: 24.094

8.  Direct comparison of a dietary portfolio of cholesterol-lowering foods with a statin in hypercholesterolemic participants.

Authors:  David J A Jenkins; Cyril W C Kendall; Augustine Marchie; Dorothea A Faulkner; Julia M W Wong; Russell de Souza; Azadeh Emam; Tina L Parker; Edward Vidgen; Elke A Trautwein; Karen G Lapsley; Robert G Josse; Lawrence A Leiter; William Singer; Philip W Connelly
Journal:  Am J Clin Nutr       Date:  2005-02       Impact factor: 7.045

9.  Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease.

Authors:  M de Lorgeril; S Renaud; N Mamelle; P Salen; J L Martin; I Monjaud; J Guidollet; P Touboul; J Delaye
Journal:  Lancet       Date:  1994-06-11       Impact factor: 79.321

10.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.

Authors:  Salim Yusuf; Steven Hawken; Stephanie Ounpuu; Tony Dans; Alvaro Avezum; Fernando Lanas; Matthew McQueen; Andrzej Budaj; Prem Pais; John Varigos; Liu Lisheng
Journal:  Lancet       Date:  2004 Sep 11-17       Impact factor: 79.321

View more
  9 in total

1.  Do Statins Reduce the Health and Health Care Costs of Obesity?

Authors:  Étienne Gaudette; Dana P Goldman; Andrew Messali; Neeraj Sood
Journal:  Pharmacoeconomics       Date:  2015-07       Impact factor: 4.981

2.  Statins Reduce the Risks of Relapse to Addiction in Rats.

Authors:  Claudia Chauvet; Celine Nicolas; Claire Lafay-Chebassier; Mohamed Jaber; Nathalie Thiriet; Marcello Solinas
Journal:  Neuropsychopharmacology       Date:  2015-10-15       Impact factor: 7.853

3.  Wealth and inequality gradients for the detection and control of hypertension in older individuals in middle-income economies around 2007-2015.

Authors:  María Fernanda García; Philipp Hessel; Paul Rodríguez-Lesmes
Journal:  PLoS One       Date:  2022-07-08       Impact factor: 3.752

4.  Incident Rheumatoid Arthritis Following Statin Use: From the View of a National Cohort Study in Korea.

Authors:  Mi Jung Kwon; Joo-Hee Kim; Ji Hee Kim; Hye-Rim Park; Nan Young Kim; Sangkyoon Hong; Hyo Geun Choi
Journal:  J Pers Med       Date:  2022-04-01

5.  The Long-Term Benefits of Increased Aspirin Use by At-Risk Americans Aged 50 and Older.

Authors:  David B Agus; Étienne Gaudette; Dana P Goldman; Andrew Messali
Journal:  PLoS One       Date:  2016-11-30       Impact factor: 3.240

6.  Is treatment "intensity" associated with healthier lifestyle choices? An application of the dose response function.

Authors:  Eleonora Fichera; Richard Emsley; Matt Sutton
Journal:  Econ Hum Biol       Date:  2016-09-11       Impact factor: 2.184

7.  Lifestyle Changes in Relation to Initiation of Antihypertensive and Lipid-Lowering Medication: A Cohort Study.

Authors:  Maarit J Korhonen; Jaana Pentti; Juha Hartikainen; Jenni Ilomäki; Soko Setoguchi; Danny Liew; Mika Kivimäki; Jussi Vahtera
Journal:  J Am Heart Assoc       Date:  2020-02-05       Impact factor: 5.501

8.  How do individuals' health behaviours respond to an increase in the supply of health care? Evidence from a natural experiment.

Authors:  Eleonora Fichera; Ewan Gray; Matt Sutton
Journal:  Soc Sci Med       Date:  2016-05-07       Impact factor: 4.634

9.  On Portfolios of Preventive Decisions for Multiple Health Risks - Evidence from US-Based Data.

Authors:  Christophe Courbage; Veronika Kalouguina
Journal:  Healthc Policy       Date:  2020-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.